BioMonde - Larval Therapy

07/11/2025

BioMonde are looking forward to exhibiting at next week!

Visit us on Stand 1 to increase your knowledge of 🐛
We also have lots of merch and goodies to give away 😊

See you there! 💙

06/11/2025

Did you know that we have cases available in video format via

These are perfect for including in your teaching presentations on study days, or why not show them on a screen if you are hosting refresher training for your team.

Here is a video version of a Case Study featuring ⬇

https://loom.ly/MhlOxZc

Using Larval Therapy on Haematomas | Wound Care Case StudyIn this video, we show you how Larval Therapy was used to debride a haematoma on a patient. The pat...

31/10/2025

When looking at the various options available to you as clinicians. Patient safety is an extremely important, if not the most important, aspect to consider.

The safety and efficacy of has been proven by the following:

✅ 5 Randomised Controlled Trials conducted.
✅ Evidenced in over 500 Clinical and Scientific publications.
✅ Documented as being used safely on over 1,000 patients.

🔍 Armstrong et al., 2005.

Today we ask the question, what level of evidence would you like to see for the products you use? Let us know by leaving a comment below ⬇

30/10/2025

Want to provide your team with the knowledge and confidence to apply and care for patients with Larval Therapy, but just don't have enough hours in a day?

At BioMonde, we understand how very precious your time is. Which is why we have developed our expert learning resources, to be available whenever you need them.

is remote training that is immersive, educational and realistic. Schedule a remote training session today.

👉🏻 Book here: https://loom.ly/HIOlNes

28/10/2025

Watch below to see a Case Study where was used in conjunction with NPWT and VAC, to treat a dehisced surgical donor site.

Download a paper copy of this week's : https://loom.ly/jSAWlqs

27/10/2025

Larval Therapy increases SKIN GRAFT SUCCESS ➡ 🔍 Nishijima A, 2017

A research paper by Nishijima, published in 2017, discusses how Larval Therapy Is able to provide favourable wound bed preparation for skin grafting.

In the cases outlined, skin grafts are successfully taken, following just one or two rounds of Larval Therapy treatment. Prior to grafting, surface necrosis was diminished and granulation formation noted.

Read the paper in full: https://loom.ly/qOB3pVc

24/10/2025

Did you know that we are one of the only suppliers in the world to offer bagged larvae, as opposed to larvae that is applied loose onto the wound.

We thought that we would share 5 simple benefits, of using bagged larvae as your debridement tool:

1. Fuss-free application, that takes less than 5 minutes of your time.
2. Patients are more accepting of bagged larvae, compared to loose.
3. Larvae are safely contained for the duration of treatment.
5. Debridement takes place through the bag, meaning larvae are never in direct contact with the wound bed.

23/10/2025

Whatever your style of , we have education to suit!

In the spotlight this week, .

A varied mixture of video tutorials, FAQs, and case studies. Find the answer to a question in seconds, quickly share information with your team, and boost your knowledge of larval debridement in the process.

Plus, did you know that you can access in two ways...

Either via our website: https://loom.ly/xmMsAZ4
Or by subscribing to our YouTube Channel: https://loom.ly/xPA0A6Y

20/10/2025

Up to 98% PROBABILITY OF DEBRIDEMENT with Larval Therapy ➡🔍 Campbell N, 2014

A study conducted by N Campbell in 2014 states, "Efficient debridement provides an opportunity to reduce the cost of care by reducing treatment time. The current study found the wounds of 67 of 68 patients (98.5%) were 90% debrided within 1 week, and the cost of nursing visits was 67% less the week following debridement."

This highlights how efficient debridement with Larval Therapy not only benefits patients, but can also have a significant impact on cost-effectiveness for both acute and community wound care practices.

Read in full here: https://loom.ly/va0mMNc

Further relevant reading:
Gilead L, 2012 👉🏻 https://loom.ly/nrn-aD0
Milne C, 2010 👉🏻 https://loom.ly/W1rGTAM

17/10/2025

Are you confident in knowing when to use Larval Therapy?
Below, we explain what it is and when it can be used in .

⬇

If a wound is not moving through the stages of healing normally, Larval Therapy may be able to help.

BioBag® is a biosurgical wound dressing containing aseptically produced living larvae of the greenbottle fly 𝘓𝘶𝘤𝘪𝘭𝘪𝘢 𝘴𝘦𝘳𝘪𝘤𝘢𝘵𝘢. The larvae remove devitalised tissue and bacterial burden from wounds, this process is often an essential step before wound healing can occur.

The effective use of Larval Therapy for wound debridement has been widely reported in published literature for the treatment of many types of chronic or non-healing wounds such as:

✅ Diabetic ulcers
✅ Pressure ulcers
✅ Dehisced or non-healing surgical wounds
✅ Haematoma
✅ Venous, arterial, and mixed aetiology leg ulcers
✅ Burns
✅ Necrotising fasciitis
✅ Pyoderma gangrenosum
✅ Calciphylaxis
✅ Certain fungating or ulcerating malignant wounds

Read more about when to use on our website: https://loom.ly/uTkCf9I

16/10/2025

Boost your knowledge on Larval Therapy this autumn with .

This free educational resource allows you to learn in your own time, through a series of modules. You will be rewarded with a certificate for each completed, perfect for adding to your CPD file.

BioMonde ACADEMY covers all aspects of Larval Therapy:

Module 1: Appling BioBag
Module 2: Daily Care
Module 3: Promoting Viability
Module 4: Production Process
Module 5: Infected Wounds
Module 6: Dehisced Wounds
Module 7: Eradicating Biofilm

Start your learning journey today: https://loom.ly/fbYMB2E

13/10/2025

Larval Therapy can contribute to a REDUCTION IN THE USE OF ANTIBIOTICS 💊 🔍 Tian X, 2013

A meta-analysis conducted by Tian in 2013, observed differences in patient groups when treated with Larval Therapy (referred to as Maggot Debridement Therapy or MDT) compared to standard care for diabetic foot ulcers.

The results of the study suggested that the group was significantly superior to the control group in the number of antibiotic-free days.

At the time of writing, the author explains how Larval Therapy re-emerged, due to the rise in chronic wounds and the emergence of antibiotic resistant strains of bacteria, such as meticillin-resistant Staphylococcus aureus (MRSA).

Read the meta-analysis in full here: https://loom.ly/NRVz-aY